YARGESA 100 MG Oral Capsule
- RxCUI
- 2642350
- RxNorm name
- YARGESA 100 MG Oral Capsule
- Display name
- YARGESA 100 MG Oral Capsule
- Full name
- YARGESA 100 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Yargesa | MIGLUSTAT | Edenbridge Pharmaceuticals LLC. | 2b371dfe-e2b0-47fe-b677-a7bde7149f87 | 2025-12-17 | Warnings, Adverse reactions | 2642350 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2b371dfe-e2b0-47fe-b677-a7bde7149f87 | YARGESA 100 MG Oral Capsule | PSN | 5 | These highlights do not include all the information needed to use YARGESA safely and effectively. See full prescribing information for YARGESA. YARGESA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20251217 |
| 2b371dfe-e2b0-47fe-b677-a7bde7149f87 | Yargesa 100 MG Oral Capsule | SY | 5 | These highlights do not include all the information needed to use YARGESA safely and effectively. See full prescribing information for YARGESA. YARGESA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20251217 |
| 2b371dfe-e2b0-47fe-b677-a7bde7149f87 | miglustat 100 MG Oral Capsule [Yargesa] | SBD | 5 | These highlights do not include all the information needed to use YARGESA safely and effectively. See full prescribing information for YARGESA. YARGESA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | 20251217 |